Drugs

From ephemeral tattoos to vagus nerve oil to a grape-waste backpack, these biotech-inspired gifts will be sure to delight and inspire.

The technique of targeting bacteria with viruses that destroy them is making a comeback, and it could help in the battle against antibiotic resistance.

Open-label placebos may defy logic, but scientists explore promising new treatment possibilities.

Senolytics that target age-related “zombie” cells could be game-changing for extending lifespans and enabling long-haul space travel.

An entrepreneur with his own rare disease finds a way to align incentives and needs to support research on rare diseases.

As psychedelics are integrated into mainstream medicine, experts weigh the benefits and costs of solo versus group therapy.

Bone marrow transplants are harrowing. Agnieszka Czechowicz is working to make them safer.

DARPA is developing an implantable device with bioengineered cells for treating everything from traveler’s diarrhea to jet lag.

Forty years after a 1981 report hinted at the coming HIV/AIDS pandemic, we look at how the response to global public health threats has changed.

Cells we were taught to ignore have been caught on tape doing the unthinkable.

For the millions of people suffering with daily physical pain, nerve stimulation and gene editing offer new hope beyond addictive opioids.

Mushrooms are waiting for their moment in medicine.

Some tech and drug enhancements are banned as unfair, but ironically they could end up leveling the playing field.

Deep learning uncovers the potential of existing medications to target different diseases.

Low levels of the naturally occurring, soft shiny metal could reduce violence and enhance moods for all.